Psyence Group Inc. 13D/13G Filings for Psyence Biomedical Ltd. (PBM)

Psyence Group Inc. 13D and 13G filings for Psyence Biomedical Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-03-25
5:27 pm
Purchase
2025-03-2513DPsyence Biomedical Ltd.
PBM
Psyence Group Inc.84,840
14.990%
84,840increase
(New Position)
Filing